One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot known as ...

A patient shows you their chat with a “therapy” bot, which reads: “I just lost my job. What bridges over 25 meters are in NYC ...

Dhruv Bhutani has been writing about consumer technology since 2008, offering deep insights into the Android smartphone landscape through features and opinion pieces. He joined Android Police in 2023, ...

When Apple announced the Apple Journal app in 2023, I was pretty excited. As an old-school physical journal aficionado, I’ve tried loads of journaling apps going back to the early days of smartphones ...

Background CYP2C19 genotyping has been widely studied to guide antiplatelet therapy in cardiovascular disease; however, its role in neurointerventional procedures, particularly for unruptured ...

Grow Therapy, a hybrid mental health provider, is introducing AI-powered journaling to help patients reflect between therapy sessions. The announcement marks the first time the company is offering ...

It might be on your bookshelf, in a junk drawer or collecting dust under a pile of papers you flung onto your desk, but there’s a good chance you have a journal. A collection of untouched blank pages ...

Brensocatib (Brinsupri; Insmed) gains FDA approval as the first treatment for bronchiectasis, offering hope to patients with the chronic lung disease. The FDA has approved brensocatib (Brinsupri; ...

Tumor infiltrating lymphocyte (TILs) therapy or tumor-derived autologous T cell immunotherapy is a form of immunotherapy that uses your body’s own immune cells to target and destroy cancer. It ...

Investors have struck a deal to buy a majority stake in HistoSonics, valuing the company whose noninvasive therapy for liver tumors shows promise in other diseases at $2.25 billion. An investor group ...

Surgical procedure. Image by Pfree2014 - Own work, CC BY-SA 4.0 Surgical procedure. Image by Pfree2014 - Own work, CC BY-SA 4.0 “Dancing molecules”, as dubbed by the researchers, is a promising new ...

EARLY treatment with intravenous immunoglobulins (IVIG) significantly improves long-term outcomes and survival in patients with anti-IgLON5 disease, according to findings from a large international ...